Canagliflozin vs Rituximab

Canagliflozin vs Rituximab: Overview

This comparison examines the pharmacological differences between Canagliflozin and Rituximab.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S.

Molecular Weight: Canagliflozin — 444.5170 g/mol.

Type: Canagliflozin — Small molecule; Rituximab — Antibody.